Picture of bioXXmed AG logo

T5O bioXXmed AG Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for bioXXmed AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M
Source:ARSARSARS
Standards:
Status:FinalFinalFinal
fx
Preliminary
fx
Preliminary
Net Income/Starting Line-1.42-1.27-1.84
Depreciation
Non-Cash Items0.20.10.207
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.070.245-0.047
Change in Other Assets
Change in Other Liabilities
Cash from Operating Activities-1.26-0.911-1.66
Capital Expenditures-0.01-0.014-0.003
Purchase of Fixed Assets
Other Investing Cash Flow Items-3.29-2.41-4.8
Sale of Fixed Assets
Purchase of Investments
Cash from Investing Activities-3.3-2.42-4.8
Financing Cash Flow Items-0.199-0.0150
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.182.666.02
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.627-0.678-0.44